Value of Optic Nerve MRI in Multiple Sclerosis Clinical Management: A MAGNIMS Position Paper and Future Perspectives

Jaume Sastre-Garriga*, Angela Vidal-Jordana, Ahmed T Toosy, Christian Enzinger, Cristina Granziera, Jette Frederiksen, Olga Ciccarelli, Massimo Filippi, Xavier Montalban, Mar Tintore, Deborah Pareto, Àlex Rovira, MAGNIMS Study Group

*Corresponding author af dette arbejde
4 Citationer (Scopus)

Abstract

The optic nerve is frequently involved in multiple sclerosis (MS). However, MRI of the optic nerve is considered optional in the differential diagnosis of optic neuropathy symptoms either at presentation or in established MS. In addition, unlike spinal cord imaging in comparable scenarios, no role is currently recommended for optic nerve MRI in patients presenting with optic neuritis for its confirmation, to plan therapeutic strategy, within the MS diagnostic framework, nor for the detection of subclinical activity in established MS. In this article, evidence related to these 3 aspects will be summarized and gaps in knowledge will be highlighted, including (1) the acquisition challenges and novel sequences that assess pathologic changes within the anterior visual pathways; (2) the clinical implications of quantitative magnetic resonance studies of the optic nerve, focusing on atrophy measures, magnetization transfer, and diffusion tensor imaging; and (3) the relevant clinical studies performed to date. Finally, an algorithm for the application of optic nerve MRI will be proposed to guide future studies aimed at addressing our knowledge gaps.

OriginalsprogEngelsk
Artikelnummere209677
TidsskriftNeurology
Vol/bind103
Udgave nummer3
ISSN0028-3878
DOI
StatusUdgivet - 13 aug. 2024

Fingeraftryk

Dyk ned i forskningsemnerne om 'Value of Optic Nerve MRI in Multiple Sclerosis Clinical Management: A MAGNIMS Position Paper and Future Perspectives'. Sammen danner de et unikt fingeraftryk.

Citationsformater